Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra versus single conventional antirheumatic drug for refractory adult-onset Still's disease
2005-003173-24Phase 2Completed
- Sponsor
- Helsinki University Hospital
- Start
- Nov 2005
- Modality
- Small Molecules, Cytokines & Interferons → Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of anakinra, methotrexate, azathioprine, leflunomide, cyclosporine and 1 more in adult-onset Still's disease (AOSD) (2 arms), sponsored by Helsinki University Hospital. Primary endpoint: Remission after two months. Started Nov 2005; status: completed.
02
Drugs
anakinramethotrexateazathioprineleflunomidecyclosporine
03
Conditions
adult-onset Still's disease (AOSD)
Beyond the preview
Go deeper on 2005-003173-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003173-24.